Compass Therapeutics (CMPX) Tax Provisions (2019 - 2021)

Compass Therapeutics (CMPX) posted Tax Provisions of -$13000.0 for Q4 2021, down 140.62% sequentially from $32000.0 in Q3 2020.

Compass Therapeutics (CMPX) Tax Provisions (2019 - 2021) Analysis & Trends

Compass Therapeutics has reported Tax Provisions for 3 years, with the latest figure at -$13000.0 in Q4 2021.

Quarterly Tax Provisions changed N/A year-over-year to -$13000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was -$13000.0 (down 120.31% YoY) and the FY2020 annual result came in at $32000.0, down 64.84% from the prior year.
Tax Provisions retreated to -$13000.0 in Q4 2021 per CMPX's latest filing, from $32000.0 in the prior quarter.
Over five years, Tax Provisions peaked at $81000.0 in Q3 2019 and troughed at -$13000.0 in Q4 2021.
A 3-year average of $33833.3 and a median of $32000.0 in 2020 frame the typical range for Tax Provisions.
The widest YoY moves for Tax Provisions: up 41.82% in 2020, down 60.49% in 2020.
Over 3 years, Tax Provisions stood at $81000.0 in 2019, then plunged by 60.49% to $32000.0 in 2020, then tumbled by 140.62% to -$13000.0 in 2021.
According to Business Quant data, Tax Provisions over the past three periods registered -$13000.0, $32000.0, and $32000.0 for Q4 2021, Q3 2020, and Q2 2020 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	59.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	75.45 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	267.73
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	13.31 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	1.90 Mn
10	Compass Therapeutics	405.20 Mn	405.20 Mn	-	-

Download Data